In the war against cancer, one of the most critical battles is waged on a cellular level as T cells from the immune system are altered in the lab to attack cancer cells. This form of immunotherapy, called chimeric antigen receptor (CAR) T-cell therapy, can be a life-saving treatment resulting in tumor control lasting ten years or longer. 

Researchers from Trinity College Dublin have developed a new gene therapy approach that shows promise for treating the dry form of Age Related Macular Degeneration (AMD) – a progressive eye disease that affects up to 10% of adults over 65 years of age and is a leading cause of severe vision impairment and blindness in this age group.

Many tumor cells mist themselves with a protective perfume that disables the immune system. But a drug already approved for other purposes can apparently render this weapon harmless. This is shown in a study by the University of Bonn and the University Medical Center Hamburg-Eppendorf, which has now appeared in the Journal for ImmunoTherapy of Cancer. The researchers now want to further optimize the compound. In the medium term, this could pave the way for new anti-cancer drugs.

The Subject expert committee, SEC of CDSCO recommended grant of permission for manufacturing and marketing and permission to conduct the Phase IV Clinical trial of Sovateltide injection by Pharmazz India.

Pharmazz India has submitted an application to receive permission for manufacturing, marketing and conduct phase IV trial in the country. Earlier SEC meeting held on 28.06.2022, the firm presented a proposal for permission for manufacturing and marketing along with Phase IV Clinical trial protocol before the committee.

Tamil Nadu All Registered Pharmacists Welfare Association requesting Pharmacy council of India to not conduct the exit examination for Pharmacists.

The General Secretary, of TNARPW association said that, we have received notification about exit exam for pharmacy students for upcoming November 2022. We are not happy by this announcement actually. Our association clearly stands with welfare of public at all the time. But we are expecting some response from PCI for our questions.

National Pharmaceutical Pricing Authority, NPPA has rejected the application of Intas Pharmaceuticals for exemption from the provisions of Drug Price Control Order, DPCO, 2013 under Para 32 (iii) for the formulations Clozapine Extended Release Capsules.

The expert committee of NPPA had received application from Intas Pharmaceuticals for exemption from the provisions of DPCO 2013 under para 32 (iii) for the formulations Clozapine extended release capsules 12.5 mg, 25 mg, 50 mg, 100 mg and 200 mg.

Glenmark Pharma Monroe, North Carolina (USA) based Facility has received a communication from the US FDA indicating the inspection classification as Official Action Indicated (OAI).

The OAI classification implies interalia that the US FDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved.

The National Institute of Animal Nutrition and Physiology (NIANP) was established on 24th November 1995 at Bangalore under the aegis of Indian Council of Agricultural Research (ICAR), New Delhi. The Institute is mandated to conduct basic and fundamental research with respect to animal feed resource management using physiological-nutritional approaches to improve animal productivity and profitability of livestock farmers.

Post : Senior Research Fellow (SRF) (One position)

CSIR-Centre for Cellular and Molecular Biology, Hyderabad (CSIR-CCMB) is a Premier Research Laboratory under the Council of Scientific & Industrial Research (CSIR), involved in multidisciplinary R&D programmes of both basic and applied nature across scientific disciplines of biological science for economic, environmental and societal benefits for the people of India.

As a leading research-driven pharmaceutical and biotechnology company, Laurus Labs aims to improve the quality of life for millions around the world  We develop innovative medicines that greatly improve health outcomes for patients with an unremitting focus on quality and affordability. We work with all the top 10 generic pharmaceutical companies in the world. We sell our APIs in 56 countries. Our major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.

AIIMS Raipur is one of the SIX AIIMS healthcare institutes being established by the Ministry of Health & Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojna (PMSSY). With the aim of correcting regional imbalances in quality tertiary level healthcare in the country, and attaining self sufficiency in graduate and postgraduate medical education and training the PMSSY planned to set up 6 new AIIMS like institutions in under served areas of the country.

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea, Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples wounds. Johnson & Johnson is ranked by Fortune Magazine as the 3rd most Admired Pharmaceutical Company in the world with an outstanding product range as well as an extensive research base with a number of life saving original research molecules. Our over 125,000 employees in 60 countries are united in a common mission: To help people everywhere live longer, healthier, happier lives.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.  Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others.

VKT Pharma is a Quality driven pharmaceutical company with vertically integrated company spanning across entire pharmaceutical value chain from product development to delivery, with established credentials in Research & Development, Manufacturing and Marketing of Solid Dosage Forms with special focus on Tablets, Capsules & Ready to Fill Immediate or Modified release Pellets for a wide range of generic drug formulations in various Therapeutic segments.

Global pharma major Lupin Limited (Lupin) has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Formoterol Fumarate Inhalation Solution.

Micro Labs, makers of Dolo 650, has said that these are baseless allegation over Rs. 1000 crore freebies to doctors. FMRAI - a body of medical representatives alleged that the pharma company that makes Dolo spent Rs 1,000 crores in the form of freebies to doctors as incentives for them to prescribe the drug, and the matter subsequently came under the scanner of the Supreme Court.

Indian pharmaceutical sector will log a moderate revenue growth of 7-9 percentage (pc) this fiscal, similar to the last fiscal, due to headwinds in export sales in the regulated markets and high-base effect in the domestic formulations business, reported by CRISIL which studied 184 drug makers that account for 55 pc of the Rs 3.4 lakh crore-a-year sector revenue.